Cargando…
Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
The introduction of immune checkpoint inhibitors (ICIs) in oncologic therapies has led to a paradigm shift in cancer treatment. ICIs have increased the overall survival in patients with malignant melanoma, small-cell lung cancer, and many other tumor entities. Despite their clinical benefits, these...
Autores principales: | Duong, Sophie L., Prüss, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294109/ https://www.ncbi.nlm.nih.gov/pubmed/35043373 http://dx.doi.org/10.1007/s13311-022-01184-0 |
Ejemplares similares
-
Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021) -
“Hirnsymptome bei Carcinomatose” — Hermann Oppenheim and an Early Description of a Paraneoplastic Neurological Syndrome
por: Schulz, Paulina, et al.
Publicado: (2015) -
Paraneoplastic neurological syndromes
por: Honnorat, Jérôme, et al.
Publicado: (2007) -
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020) -
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)